Table 5. Results of the in Vivo Efficacy Screening.

	inhibition (%)
compd	day 3 PE	day 6 PE
4	0.0	0.0
12	9.0	0.0
24	0.0	0.0
33	53.6	26.9
34	41.4	26.8
45	85.7	61.0
46	83.9	69.0
50	44.3	29.1
58	60.0	28.8
amodiaquine	95.5	99.9
artesunate	97.0	81.0
atovaquone	96.3	99.8